Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Department of Health and Human Services”

677 pharma patents match "The United States of America, as represented by the Department of Health and Human Services" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 677
Index total 30,257
Page 6 / 29

Quick answer

This filtered view shows 677 pharmaceutical patents matching "The United States of America, as represented by the Department of Health and Human Services" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

677 results for “The United States of America, as represented by the Department of Health and Human Services” · 30,257 patents in full index Clear search

  1. US 7776883

    Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  2. US 7776607

    Mammalian selenoprotein differentially expressed in tumor cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  3. US 7771729

    Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  4. US 7771715

    Recombinant vector expressing multiple costimulatory molecules and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  5. US 7767645

    SH2 domain binding inhibitors

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted

  6. US 7763451

    Methods for preparing Bacillus anthracis protective antigen for use in vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted

  7. US 7763719

    Variants of humanized anti-carcinoma MAb CC49

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted

  8. US 7763586

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted

  9. US 7758855

    DNA promoters and anthrax vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted

  10. US 7759330

    21-substituted progesterone derivatives as new antiprogestational agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted

  11. US 7758876

    Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted

  12. US 7754676

    Defensin-antigen fusion proteins

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted

  13. US 7754420

    Methods of using cyanovirins to inhibit viral infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted

  14. US 7754227

    Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted

  15. US 7749719

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted

  16. US 7749984

    Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted

  17. US 7749967

    Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted

  18. US 7745144

    Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted

  19. US 7744902

    Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted

  20. US 7745212

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted

  21. US 7741437

    P. ariasi polypeptides, p. perniciosus polypeptides and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 22, 2010 · Expires Jun 17, 2030

    granted

  22. US 7731953

    Methods for use of TSLP and agonists and antagonists thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 8, 2010 · Expires Jun 3, 2030

    granted

  23. US 7723096

    Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the agonist peptides

    The United States of America, as represented by the Department of Health and Human Services · Granted May 25, 2010 · Expires May 20, 2030

    granted

  24. US 7723022

    Immunostimulatory nucleic acid molecules

    The United States of America, as represented by the Department of Health and Human Services · Granted May 25, 2010 · Expires May 20, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.